The complex mechanisms of Src regulation and hyperactivation in CRC discussed above may explain the lack of anticancer effect of these drugs, particularly the lack of patient stratification, drug efficacy and selectivity, resulting in significant toxicity. This evidence concerns the gene SRC and colorectal carcinoma.